Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell ...

First U.S. pivotal study for Alpha Tau to have completed enrollment, representing a critical milestone on the path towards potential FDA ...

Alpha Tau Medical Shares Early REGAIN Data: 2 Complete Responses in Glioblastoma Study

Alpha Tau Medical (NASDAQ:DRTS) presented early clinical results from the first three patients treated in its REGAIN study of Alpha DaRT for recurrent glioblastoma, with company executives and ...

Alpha Tau Announces Groundbreaking Interim Results from its U.S. Alpha DaRT® Recurrent Glioblastoma Trial, with 100% Local Disease Control, 67% Complete Response Rate, and ...

Interim results from the first three brain cancer patients treated; two of whom demonstrated complete response, with total disappearance of all ...
Yahoo Finance

Alpha Tau Reports New Positive Results in Two Upcoming Presentations at ASCO GI 2026 Symposium Showcasing Immune-Preservation and High Disease Control in Montreal Pancreatic ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Radio Ink

Study Reveals Gen Alpha’s Media Preferences and Perceptions

As radio and advertisers seek inroads into Gen Alpha, a new study is giving a new understanding of how the young generation views media, brands, and the personalities who represent them. Razorfish and ...
Variety

Gen Alpha Media Habits Come Into Focus in Paramount Study

As the first generation to live entirely within the 21st century, Gen Alpha does things its own distinctive way, and that includes media engagement preferences all its own, according to a new study.